#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myotonia Cervix carcinoma Carcinoid tumour Type IIa hyperlipidaemia Ventricular tachycardia Synovial sarcoma metastatic Hydrocephalus Hereditary angioedema with C1 esterase inhibitor deficiency Neoplasm Waldenstrom's macroglobulinaemia Hyperphagia Crigler-Najjar syndrome Dupuytren's contracture Hypophosphatasia Oropharyngeal cancer recurrent More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour – Life with Disease Phenylketonuria – Basic Information Primary immunodeficiency syndrome Angiosarcoma – Treatment Choroid melanoma – Life with Disease Haemophilia – Treatment Chronic granulomatous disease – Basic Information Alport’s syndrome – Diagnostics Hereditary neuropathic amyloidosis – Life with Disease Primary hyperoxaluria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Prasinezumab Azilsartan Medoxomil Nimorazole Soya Oil Litifilimab Ds-2325A Migalastat Midostaurin CARBACHOL Cart 19/22 T Cells 1,3-BUTYLENE GLYCOL Ammonium Chloride Magnesium Stearate Resiniferatoxin CANNABINOL ABIRATERONE DECANOATE Exagamglogene Autotemcel Taminadenant CC-97540 SODIUM BENZOATE More therapies…

    Learn about Your Condition

    Blood iron increased Sarcoidosis Hypoxia Open angle glaucoma Cerebral palsy Amnestic disorder Factor VIII deficiency Arthritis infective Colorectal adenocarcinoma Hepatorenal syndrome Niemann-Pick disease Pelvic venous thrombosis Thrombotic microangiopathy Acute kidney injury Lip and/or oral cavity cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • Study on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Mepolizumab
    • Omalizumab
    Belgium France

  • Study on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Azd8630
    • Human Igg1 Lambda Fab Fragment Against Thymic Stromal Lymphopoietin
    Belgium Czechia Denmark France Germany Italy +3

  • Study on Tezepelumab for Patients with Severe Asthma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tezepelumab
    France

  • Study on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD

    Not recruiting

    1 1
    Investigated Diseases:
    • Asthma
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Ads-013
    Poland Spain

  • Study on the Effectiveness and Safety of a Grass and Olive Pollen Allergy Vaccine for Patients with Allergic Rhinitis or Asthma

    Not recruiting

    3 1
    Investigated Drugs:
    • Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Lolium Perenne Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
    Spain

  • Study on the Effectiveness and Safety of Clustoid MM09 for Patients with Allergic Rhinitis or Rhinoconjunctivitis, with or without Mild to Moderate Asthma

    Not recruiting

    3 1
    Investigated Drugs:
    • Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
    • Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
    Spain
Previous Page
1 … 6 7 8 9 10 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!